Ticker: ISPC

Insilico Medicine (ISPC)

Biotech Healthcare Medical - Diagnostics & Research

Price 1.97

Reco Sell Potential 30 Risk 85 Updated 2026-07-25

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

Insilico Medicine is a biotechnology company focused on drug discovery and development using artificial intelligence. Its core products include AI-driven platforms for target identification, drug design, and preclinical development. The company operates primarily in the healthcare sector, with major revenue sources stemming from partnerships, collaborations, and research grants aimed at advancing therapeutic solutions for various diseases.

Investment Profile

The investment profile of Insilico Medicine is more aligned with growth investors due to its focus on innovative technologies and potential for future revenue generation. However, the high volatility and significant risks associated with its operations may not appeal to conservative investors. The stock may be suitable for those with a medium to long-term investment horizon, seeking exposure to the biotech sector.

Category: Biotech Sector: Healthcare Industry: Medical - Diagnostics & Research Investment style: Growth Horizon: Medium-term Company type: Niche Player

Fundamental metrics (experimental) Updated: 2026-07-24

EPS (TTM) — earnings per share for the last 12 months, $: -326.00
Revenue QoQ — quarter-over-quarter revenue growth: 201.4%
EPS surprise: 84.5%
20d volatility: 4.7%

AI recommendation changes

Date	Before	After	Reason
2026-07-15	Hold	Sell	High volatility and negative momentum raise significant concerns.
2026-07-11	Sell	Hold	High volatility with uncertain fundamentals and market conditions.
2026-07-09	Hold	Sell	High risk with negative momentum and weak fundamentals.
2026-06-25	Sell	Hold	High volatility and negative fundamentals raise concerns.
2026-06-23	Hold	Sell	High volatility and negative momentum raise significant concerns.
2026-06-19	Sell	Hold	High volatility and negative momentum raise concerns.
2026-06-03	Hold	Sell	High volatility and negative momentum raise significant concerns.
2026-05-16	Sell	Hold	High volatility and negative fundamentals raise concerns.
2026-05-08	—	Sell	scenario_deterioration
2026-05-08	Hold	Hold	Компания демонстрирует впечатляющий рост за последние месяцы, однако отрицательный EPS и снижение выручки указывают на высокие риски. Рекомендуется удерживать акции до более ясных сигналов о стабильности финансовых показ
2026-04-29	Sell	Hold	Компания показывает впечатляющий рост за последние месяцы, несмотря на отрицательный EPS и снижение выручки. Это может свидетельствовать о высоком интересе инвесторов и потенциале для дальнейшего роста.
2026-04-01	Hold	Sell	scenario_deterioration
2026-03-30	—	Hold	Компания показывает значительное падение цены акций за последние месяцы, что указывает на высокие риски и отсутствие стабильных финансовых показателей.

News Page 1 of 1

Nothing yet